On Apr 16, 2018 Celyad SA – American Depositary Shares (NASDAQ:CYAD) Shorts Strengthened By 51.81%

April 16, 2018 - By Damon Whitfield

Celyad SA (NASDAQ:CYAD) Corporate Logo

Celyad SA – American Depositary Shares (NASDAQ:CYAD) registered an increase of 51.81% in short interest. FINRA published in April CYAD’s total 125,700 short interest. The 82,800 previous shares are up with 51.81%. 14 days will cost CYAD With 8,700 average volume to restore its previous position. 1.91% is Celyad SA – American Depositary Shares float short.

The stock increased 0.16% or $0.0512 during the last trading session, reaching $31.4312.Currently Celyad SA is after 0.00% change in last April 16, 2017. CYAD has 1,045 shares volume. CYAD underperformed by 11.55% the S&P500.

Celyad SA, a biopharmaceutical company, focuses on engineered cell therapy treatments.The firm is worth $318.33 million. It operates in two divisions, Cardiology and Immuno-oncology.Currently it has negative earnings. The companyÂ’s lead product candidate in cardiovascular disease is C-Cure, an autologous cell therapy for the treatment of patients with ischemic heart failure.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.